Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-13-017005
Filing Date
2013-03-14
Accepted
2013-03-14 17:23:50
Documents
1
Period of Report
2013-02-28

Document Format Files

Seq Description Document Type Size
1 FEBRUARY DARA OPTION GRANT rrd374014.html 4  
1 FEBRUARY DARA OPTION GRANT rrd374014.xml 4 4600
  Complete submission text file 0001181431-13-017005.txt   6209
Mailing Address 8601 SIX FORKS ROAD SUITE 160 RALEIGH NC 27615
Business Address 8601 SIX FORKS ROAD SUITE 160 RALEIGH NC 27615 919-861-0202
DARA BioSciences, Inc. (Issuer) CIK: 0000919745 (see all company filings)

EIN.: 043216862 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 11 TOPSTONE ROAD REDDING CT 06896
Business Address
JAEGER STEPHEN O (Reporting) CIK: 0001243960 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-23776 | Film No.: 13691372